Saturday, February 28, 2015

Quality of compounded bevacizumab varies

FEB 20, 2015 by Carl Danzig, MD
Samples from various U.S. compounding pharmacies showed significant variability and lower concentrations than bevacizumab acquired directly from Genentech, although the clinical implications of this are not yet known.
Editors' Choice

No comments: